Beta-lactam-specific resistant mutants of Staphylococcus aureus.
about
Beta-lactam resistance in Staphylococcus aureus cells that do not require a cell wall for integrityContribution of peptidoglycan amidation to beta-lactam and lysozyme resistance in different genetic lineages of Staphylococcus aureus.Borderline methicillin-susceptible Staphylococcus aureus strains have more in common than reduced susceptibility to penicillinase-resistant penicillinsFurther characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding proteins.Presence of an additional penicillin-binding protein in methicillin-resistant Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, and Staphylococcus simulans with a low affinity for methicillin, cephalothin, and cefamandInsertional inactivation of the mec gene in a transposon mutant of a methicillin-resistant clinical isolate of Staphylococcus aureusNew mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity.Consequences of the interaction of beta-lactam antibiotics with penicillin binding proteins from sensitive and resistant Staphylococcus aureus strains.Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus.Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings.Methicillin-resistant staphylococci.Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus.Nonradioactive DNA probe for detection of gene for methicillin resistance in Staphylococcus aureus.Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus.Borderline susceptibility to antistaphylococcal penicillins is not conferred exclusively by the hyperproduction of beta-lactamase.Structural characterization of an abnormally cross-linked muropeptide dimer that is accumulated in the peptidoglycan of methicillin- and cefotaxime-resistant mutants of Staphylococcus aureus.Antimicrobial resistance of Staphylococcus aureus: genetic basis.Detection of methicillin-resistant staphylococci by using the polymerase chain reaction.Cloning, characterization, and inactivation of the gene pbpC, encoding penicillin-binding protein 3 of Staphylococcus aureusTOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureusInteraction of FCE 22101 with penicillin-binding proteins of Staphylococcus aureus.Construction of a water-soluble form of penicillin-binding protein 2a from a methicillin-resistant Staphylococcus aureus isolate.Characterization of penicillin-binding protein 2 of Staphylococcus aureus: deacylation reaction and identification of two penicillin-binding peptides.Antibiotic Resistance as a Stress Response: Recovery of High-Level Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus "Auxiliary" (fem) Mutants by Induction of the Stringent Stress Response.Kinetics of penicillin binding to penicillin-binding proteins of Staphylococcus aureus.Testing of methicillin resistance by in vitro susceptibility and the presence of the mecA gene in clinical Staphylococcus aureus isolates in Finland.In vitro and in vivo studies of the use of some medicinal herbals against the pathogen Aeromonas hydrophila in goldfish.In vitro development and stability of tolerance to cloxacillin and vancomycin in Staphylococcus aureus.Characterization ofStaphylococcus aureusCell Wall Glycan Strands, Evidence for a New β-N-Acetylglucosaminidase Activity
P2860
Q24534653-C0C56476-E614-4778-A058-CC3D34453293Q33730107-5262AB42-A88C-40E2-84B4-CAB274A10E94Q35130024-ED177379-5C7D-4CDA-B5F6-CDDF38795EB1Q35255469-656FD82E-BD8B-4F93-AFE4-B3896E103A5AQ35272179-66B730BD-F22B-42FB-B1DE-C6D8DE8325F3Q35273413-2D92706B-E577-4052-8554-17A55263D912Q35358571-834C0569-0338-485C-9CFA-0A4C84BAA37AQ35642011-9AC878F8-31E5-4AE1-B3C5-5889A60320FDQ36087154-F411FBC9-56A2-42B6-B858-FBCF4B83A2F2Q36478309-A2B5BF5E-4B1E-405D-BFDB-744440A8BEF7Q36632851-50FC37A8-DF6E-4DA6-9DE6-5767FF986C07Q36717643-0DD30701-96F3-42CB-93E8-64C2EF879EFFQ36753189-1CA063D5-4798-484B-9EEF-3216CF179EEBQ36753305-B62BF1A5-C00F-4A78-A6F8-C1547FB1BF15Q36755455-ED1F7650-7DD3-443A-A57D-085C7EFDED36Q36889926-9086BE4E-14EA-443A-B114-280607805477Q37063182-CFCD87EA-F193-4CFD-8070-ECFFF4EB576AQ37123101-2417F5B7-FEC2-49D1-A33E-10099CFCDFC1Q39499081-DE3F9FDB-C8DA-4634-B85B-76D6E6B7EC69Q39779720-121BF7EA-D124-40BF-BA1F-3259AA36282EQ39814845-085B9110-D0A8-45B4-BB42-FB7ED6C6D7D8Q39875816-33321EF3-50D4-4E0D-AE8F-F5D782BC4719Q39875894-8EE69A27-B679-4032-8EF5-674C3EFF362DQ40166256-01F76616-583B-4C6D-9203-447CEA652D93Q42151559-E038126D-51B1-4C84-84AD-D2626750806BQ44966026-A2454A23-0143-48B6-8CFA-5F846D8F22ABQ50631233-6D7043D1-D5D0-4849-BE00-B9107CD127BDQ54196268-689EC21D-2173-4159-8913-37D82E306886Q57077255-42F7C0FD-BA92-4FE9-A4BC-94357EDD1C39
P2860
Beta-lactam-specific resistant mutants of Staphylococcus aureus.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Beta-lactam-specific resistant mutants of Staphylococcus aureus.
@en
Beta-lactam-specific resistant mutants of Staphylococcus aureus.
@nl
type
label
Beta-lactam-specific resistant mutants of Staphylococcus aureus.
@en
Beta-lactam-specific resistant mutants of Staphylococcus aureus.
@nl
prefLabel
Beta-lactam-specific resistant mutants of Staphylococcus aureus.
@en
Beta-lactam-specific resistant mutants of Staphylococcus aureus.
@nl
P2860
P356
P1476
Beta-lactam-specific resistant mutants of Staphylococcus aureus.
@en
P2093
P2860
P304
P356
10.1128/AAC.30.4.577
P407
P577
1986-10-01T00:00:00Z